KBR

KBR, Inc.

$35.72

+0.20%
Jun 2, 2026
Bobby Quantitative Model
KBR, Inc. is a global provider of technology, integrated engineering, procurement, construction, and operations and maintenance services, operating primarily within the Engineering & Construction industry under the Industrials sector. The company has established itself as a significant player in government services and sustainable technology, with a distinct competitive identity as a diversified contractor serving both public sector and industrial clients. The current investor narrative is heavily influenced by recent major contract wins, such as the Basra oil deal, which signal potential future revenue growth, but this is juxtaposed against a backdrop of recent stock price weakness and concerns over near-term revenue trends, creating a debate between long-term opportunity and short-term execution risk.

People also watch

Quanta Services

Quanta Services

PWR

Analysis
Comfort Systems USA

Comfort Systems USA

FIX

Analysis
EMCOR

EMCOR

EME

Analysis
MasTec

MasTec

MTZ

Analysis
Sterling Infrastructure, Inc. Common Stock

Sterling Infrastructure, Inc. Common Stock

STRL

Analysis

BobbyInvestment Opinion: Should I buy KBR Today?

Rating & Thesis: KBR is a Hold. The core thesis is that the stock presents a compelling valuation case with a forward P/E of 8.4x and strong cash flow, but this is counterbalanced by clear near-term fundamental deterioration and negative momentum, requiring investors to wait for evidence of a revenue turnaround before committing new capital. This aligns with the mixed but cautious analyst sentiment, where the absence of 'Sell' ratings suggests a floor but recent downgrades indicate a lack of near-term catalysts.

Supporting Evidence: The Hold rating is supported by four key data points: 1) The deeply discounted forward P/E of 8.42x, 2) Robust TTM free cash flow of $482 million supporting financial flexibility, 3) A high Return on Equity of 27.61% indicating capital efficiency, and 4) The stock's price near the lower end of its 52-week range ($29.94-$54.38), suggesting limited near-term downside if support holds. However, these positives are tempered by the 11.17% YoY revenue decline and the stock's -60.25 relative strength versus the SPY over the past year.

Risks & Conditions: The two biggest risks that could invalidate a neutral stance are a further sequential decline in revenue and a break below the $29.94 support level. This Hold rating would upgrade to a Buy if KBR demonstrates a clear reversal in its revenue trend with sequential growth, or if the forward P/E compresses further toward 7x without a deterioration in earnings estimates. Conversely, it would downgrade to a Sell on a confirmed break below the 52-week low coupled with another quarterly revenue miss. Relative to its own history and the apparent discount to sector averages, the stock is fairly valued to slightly undervalued, but this valuation is justified by the current growth headwinds.

Sign up to view all

KBR 12-Month Price Forecast

The AI assessment is neutral with medium confidence. KBR is a classic 'show me' story caught between a deeply attractive valuation and deteriorating fundamentals. The strong cash flow and low beta provide defensive characteristics, but the revenue trend must reverse to justify a more bullish stance. The recent major contract win is a potential catalyst, but it needs to materialize in reported financials. The stance would upgrade to bullish on confirmation of sequential revenue growth in the next two quarters, supported by stable or expanding margins. It would downgrade to bearish on a break below the $29.94 support level, which would signal a failure of the value proposition and likely lead to further downside.

Historical Price
Current Price $35.72
Average Target $39
High Target $54
Low Target $25

Wall Street consensus

Most Wall Street analysts maintain a constructive view on KBR, Inc.'s 12-month outlook, with a consensus price target around $46.44 and implied upside of +30.0% versus the current price.

Average Target

$46.44

3 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

3

covering this stock

Price Range

$29 - $46

Analyst target range

Buy
0 (0%)
Hold
1 (33%)
Sell
2 (67%)

Analyst coverage for KBR appears limited, with only 3 analysts providing estimates for revenue and EPS, indicating this may be a mid-cap stock with less institutional scrutiny, which can lead to higher volatility and less efficient price discovery. The consensus sentiment, inferred from recent institutional ratings, is mixed but leans cautiously optimistic, with firms like Citigroup and Truist maintaining 'Buy' ratings, while B of A Securities and UBS have shifted to or maintained 'Neutral' stances, reflecting uncertainty about the near-term outlook. The wide range in EPS estimates, from a low of $4.02 to a high of $4.44, signals meaningful divergence in analyst views on the company's profit recovery potential, contributing to the stock's unsettled trading pattern. The pattern of recent ratings shows some downgrades from 'Buy' to 'Neutral' in 2025 (e.g., B of A Securities in August, UBS in July), which likely contributed to the stock's downward pressure, though the absence of outright 'Sell' ratings suggests analysts see a floor in the valuation.

Drowning in data?

Find the real signal!

Bulls vs Bears: KBR Investment Factors

The investment debate for KBR centers on a stark tension between its deeply discounted valuation and future contract potential versus its deteriorating near-term fundamentals and negative price momentum. Currently, the bear case holds stronger evidence, as the concrete data points of an 11% YoY revenue decline, persistent stock price weakness (-32% over 1 year), and analyst downgrades outweigh the promise of future contracts and cheap multiples. The single most important factor that will resolve this thesis is whether the recently won Basra oil contract and others can successfully reverse the declining revenue trajectory evident in the last two quarterly reports. If revenue stabilizes or grows sequentially, the low forward P/E of 8.4x will appear compelling; if the decline continues, the stock's value trap characteristics will be confirmed.

Bullish

  • Deeply Undervalued Forward P/E of 8.4x: KBR trades at a forward P/E of just 8.42x, a significant discount to its trailing P/E of 12.59x, implying the market expects a substantial earnings recovery. This valuation is near the lower end of its historical range, which has seen P/E ratios as high as 25.71x, suggesting a potential value opportunity if earnings stabilize.
  • Strong Free Cash Flow Generation: The company generates robust free cash flow, with TTM FCF of $482 million, providing significant internal funding flexibility and supporting its 1.6% dividend yield. This strong cash generation underpins a healthy current ratio of 1.22 and a high Return on Equity of 27.61%, indicating efficient capital allocation.
  • Major Contract Wins Signal Future Growth: Recent news highlights a major contract win with Basra Oil, which presents a significant future revenue catalyst. This win, alongside the company's focus on sustainable technology solutions, provides a tangible growth driver that is not yet reflected in the current stock price, which is down 32% over the past year.
  • Low Beta Suggests Defensive Characteristics: With a beta of 0.472, KBR has demonstrated significantly less volatility than the broader market during its downturn. This low correlation suggests the stock may offer defensive characteristics in a portfolio, potentially limiting downside in broader market sell-offs.

Bearish

  • Severe Revenue Deceleration and Decline: Q4 2025 revenue of $1.885 billion represents an 11.17% year-over-year decline and a sequential drop from Q1 2025's $2.055 billion. This clear deceleration trend raises serious concerns about near-term business momentum and project execution, overshadowing long-term contract wins.
  • Persistent Technical Downtrend and Underperformance: The stock is in a pronounced downtrend, down 32.04% over the past year and 17.24% over the last three months, severely underperforming the S&P 500 by over 60 percentage points. Trading near its 52-week low of $29.94, the price action reflects sustained selling pressure and a lack of positive catalysts.
  • Elevated Debt Load and Low Margins: A debt-to-equity ratio of 2.08 indicates a leveraged balance sheet, which increases financial risk if revenue declines persist. Furthermore, gross margins of 15.38% and operating margins of 7.64% reflect the low-margin, project-based nature of the business, limiting profitability upside.
  • Limited Analyst Coverage and Downgrade Trend: With only 3 analysts providing estimates, KBR suffers from less institutional scrutiny, which can lead to higher volatility. The pattern of recent downgrades from 'Buy' to 'Neutral' by firms like B of A Securities and UBS in mid-2025 has contributed to the stock's negative momentum and reflects growing near-term uncertainty.

KBR Technical Analysis

The prevailing price trend for KBR is a pronounced downtrend, with the stock down 32.04% over the past year, significantly underperforming the S&P 500's 28.21% gain. With a current price of $34.95, the stock is trading near the lower end of its 52-week range of $29.94 to $54.38, positioning it at approximately 14% of the range's span from the low, which suggests deep oversold conditions but also reflects substantial negative momentum and investor pessimism. Recent momentum remains negative and aligns with the longer-term downtrend, with the stock down 17.24% over the last three months and 2.97% over the past month, indicating persistent selling pressure despite a slight deceleration in the rate of decline over the very short term. The stock's beta of 0.472 indicates it has been significantly less volatile than the broader market during this downturn, which is unusual for a cyclical industrial name and may suggest it is being treated as a defensive holding or is experiencing idiosyncratic selling. Key technical levels are clearly defined, with immediate support at the 52-week low of $29.94 and major resistance at the 52-week high of $54.38; a sustained break below $30 could trigger further technical selling, while a recovery above the $40 level, which has acted as recent resistance, would be needed to signal a potential trend reversal. The stock's relative strength readings are deeply negative, with a 1-year relative strength of -60.25 against the SPY, underscoring its severe underperformance and the need for a fundamental catalyst to change its trajectory.

Beta

0.47

0.47x market volatility

Max Drawdown

-46.4%

Largest decline past year

52-Week Range

$30-$54

Price range past year

Annual Return

-30.1%

Cumulative gain past year

PeriodKBR ReturnS&P 500
1m-4.6%+5.4%
3m-11.9%+10.9%
6m-19.9%+11.0%
1y-30.1%+28.1%
ytd-11.8%+11.4%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

KBR Fundamental Analysis

KBR's revenue trajectory shows signs of deceleration and contraction, with Q4 2025 revenue of $1.885 billion representing an 11.17% year-over-year decline, and a sequential decline from the $2.055 billion reported in Q1 2025, indicating potential headwinds in securing or executing on large projects. The company remains profitable, with Q4 2025 net income of $111 million and a net margin of 5.89%, but gross margin of 15.38% and operating margin of 7.64% reflect the relatively low-margin nature of its contract engineering and construction work. Profitability has been inconsistent quarter-to-quarter, with net income swinging from $116 million in Q1 2025 to $73 million in Q2 2025 before recovering, highlighting project-based earnings volatility and the impact of one-time items or contract adjustments. The balance sheet carries moderate financial risk, with a debt-to-equity ratio of 2.08, though the company maintains a current ratio of 1.22, indicating sufficient short-term liquidity. Cash flow generation is a strength, with trailing twelve-month free cash flow of $482 million providing internal funding flexibility, and the Return on Equity of 27.61% is robust, suggesting efficient use of shareholder capital despite the elevated debt load.

Quarterly Revenue

$1.9B

2026-01

Revenue YoY Growth

-0.11%

YoY Comparison

Gross Margin

+0.15%

Latest Quarter

Free Cash Flow

$482000000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Sustainable Technology Solutions

Open an Account, get $2 TSLA now!

Valuation Analysis: Is KBR Overvalued?

Given KBR's positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 12.59x and a forward PE of 8.42x, with the significant discount in the forward multiple implying the market expects a substantial recovery in earnings over the next twelve months. Compared to sector averages, KBR's trailing PE of 12.59x appears to be at a discount, though a precise industry average PE is not provided in the data; the low forward PE of 8.42x suggests the market is pricing in very subdued growth expectations relative to its historical profile or peers. Historically, KBR's current trailing PE of 12.59x sits well below its own historical range observed in recent quarters, which has seen PE ratios as high as 25.71x in Q4 2024 and as low as 6.26x in mid-2023, indicating the stock is near the lower end of its valuation band, which could represent a value opportunity if fundamentals stabilize. The Price-to-Sales ratio of 0.67x and EV-to-Sales of 0.88x further support a valuation that is not demanding, pricing the company at a fraction of its annual revenue, which may attract value-oriented investors if the revenue decline is seen as cyclical rather than structural.

PE

12.6x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range -95x~89x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

8.3x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: KBR faces significant financial risk from its elevated debt load, with a debt-to-equity ratio of 2.08, which could pressure the balance sheet if the current revenue decline persists. Operationally, the company is exposed to project-based earnings volatility, as evidenced by net income swinging from $116M to $73M between Q1 and Q2 2025, and low gross margins of 15.38% that limit profitability. The 11.17% year-over-year revenue decline in Q4 2025 is the most pressing risk, indicating potential headwinds in securing or executing large contracts, which is the core of its business model.

Market & Competitive Risks: The primary market risk is valuation compression, as the stock trades at a forward P/E of 8.4x, which may reflect a permanent de-rating rather than a cyclical low if growth expectations are not met. Competitive risks are inherent in the engineering and construction sector, where pricing pressure can further squeeze already thin margins. The stock's low beta of 0.472 is unusual and may not hold if the company's fundamentals continue to weaken, potentially leading to a catch-down in volatility to the downside. Recent analyst downgrades to 'Neutral' highlight growing skepticism about the near-term outlook.

Worst-Case Scenario: The worst-case scenario involves a continuation of the current revenue decline, coupled with execution issues on major new contracts like the Basra oil deal, leading to an earnings miss and a further compression of the valuation multiple. This could trigger a breach of the key technical support at the 52-week low of $29.94, unleashing further technical selling. In this adverse scenario, a realistic downside could see the stock re-test its historical max drawdown level of -46.44% from its high, which from the current price of $34.95 implies a potential loss of approximately -35%, driving the share price toward the $22-$25 range.

FAQ

The key risks are, in order of severity: 1) Fundamental Deterioration: The 11.17% YoY revenue decline could continue, invalidating the growth recovery thesis. 2) Financial Leverage: A debt-to-equity ratio of 2.08 increases risk if earnings decline. 3) Execution Risk: The company must successfully execute on major new contracts like the Basra deal to drive future revenue. 4) Technical Breakdown: A break below the $29.94 support level could trigger accelerated selling, with a historical max drawdown of -46.44% serving as a warning.

The 12-month outlook presents three scenarios. The Base Case (55% probability) sees the stock trading between $36 and $42 as revenue stabilizes but growth remains muted. The Bull Case (25% probability), driven by successful contract execution, targets $48 to $54. The Bear Case (20% probability), triggered by further revenue declines, sees the stock falling to $25-$30. The base case is most likely, assuming the company meets analyst EPS estimates of $4.23 but fails to catalyze a significant multiple re-rating due to persistent skepticism.

Based on traditional metrics, KBR appears significantly undervalued. It trades at a forward P/E of 8.42x and a Price-to-Sales ratio of 0.67x, which are deep discounts to its own historical averages and likely to sector peers. However, this discount is justified by the market's expectation of poor growth, as evidenced by the 11.17% year-over-year revenue decline. The valuation implies the market expects either continued fundamental deterioration or permanently subdued growth, making it a classic value trap if those expectations prove correct.

KBR is a speculative buy only for value investors with a high risk tolerance and a long-term horizon. At a forward P/E of 8.4x, the valuation is compelling, and TTM free cash flow of $482 million provides a margin of safety. However, with revenue declining 11.17% YoY and the stock in a persistent downtrend, it is not a good buy for growth investors or those seeking stability. The investment hinges entirely on the company successfully executing on recent contract wins like the Basra oil deal to reverse the negative revenue trend.

KBR is unsuitable for short-term trading due to its negative momentum, low analyst coverage, and project-based earnings volatility. It is only appropriate for long-term investors with a minimum horizon of 2-3 years who can wait for the thesis of contract-driven revenue recovery to play out. The stock's low beta of 0.472 suggests it has not moved with the market recently, but this is idiosyncratic; its true cyclical nature and need for a fundamental catalyst make it a patient investor's stock, not a trader's.